Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release

Journal of Molecular Biology

Volumn 410, Issue 4, 2011, Pages 716-725

  Ehrlich, Lorna S ^a   Medina, Gisselle N ^a   Carter, Carol A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Human immunodeficiency virus type 1 (HIV 1); inositol 1,4,5 triphosphate receptor (IP3R); Phosphatidylinositol (4,5) biphosphate (PI(4,5)P2); Sprouty2 (Spry2); Virus like particles (VLPs)

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ASPARTIC ACID; CALCIUM ION; GAG PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C GAMMA; SPROUTY PROTEIN; SPROUTY2 PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM SIGNALING; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; VIRUS PARTICLE; WILD TYPE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80051744355     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.04.069     Document Type: Article

References (34)

1. Freed, E. O. (2002). Viral Late Domains. J. Virol. 76, 4679-4687. (Pubitemid 34441674)
2. Bieniasz, P. D. (2009). The cell biology of HIV-1 virion genesis. Cell Host Microbe, 5, 550-558.
3. Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K. & Freed, E. O. (2004). Phosphatidylinositol (4,5) biphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad. Sci. USA, 101, 14889-14894. (Pubitemid 39410770)
4. Ehrlich, L. S., Medina, G. N., Khan, M. B., Powell, M. D., Mikoshiba, K. & Carter, C. A. (2010). Activation of the inositol (1,4,5)-triphosphate calcium gate receptor is required for HIV Gag release. J. Virol. 84, 6438-6451.
5. 2+channel: from discovery to new signaling concepts. J. Neurochem. 102, 1426-1446. (Pubitemid 47256212)
6. Balla, T., Szentpetery, Z. & Kim, Y. J. (2009). Phosphoinositide signaling: new tools and insights. Physiology, 24, 231-244.
7. Medina, G. N., Ehrlich, L. S., Chen, M. H., Khan, M. B., MD Powell, M. D. & Carter, C. A. (2011). Sprouty2 binds ESCRT-2 factor Eap20 and facilitates HIV-1 Gag release. J. Virol. In press. doi:10.1128/JVI.00141-11.
8. Minowada, G., Jarvis, L. A., Chi, C. L., Neubuser, A., Sun, X., Hacohen, N. et al. (1999). Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development, 126, 4465-4475.
9. Mason, J. M., Morrison, D. J., Basson, M. A. & Licht, J. D. (2006). Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 16, 45-54. (Pubitemid 43077094)
10. Edwin, F., Anderson, K., Ying, C. & Patel, T. B. (2009). Intermolecular interactions of Sprouty proteins and their implications in development and disease. Mol. Pharmacol. 76, 679-691.
11. Guy, G. R., Jackson, R. A., Yusoff, P. & Chow, S. Y. (2009). Sprouty proteins: modified modulators, matchmakers or missing links? J. Endocrinol. 203, 191-202.
12. Casci, T., Vinos, J. & Freeman, M. (1999). Sprouty, an intracellular inhibitor of Ras signaling. Cell Calcium, 96, 655-665. (Pubitemid 29122808)
13. Kramer, S., Okabe, M., Hacohen, N., Krasnow, M. A. & Hiromi, Y. (1999). Sprouty: a common antagonist of FGF and EGF signaling pathways in Drosophila. Development, 126, 2515-2525. (Pubitemid 29299020)
14. Reich, A., Sapir, A. & Shilo, B. (1999). Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development, 126, 4139-4147. (Pubitemid 29481570)
15. Ozaki, K., Kadomoto, R., Asato, K., Tanimura, S., Itoh, N. & Kohno, M. (2001). ERK pathway positively regulates the expression of Sprouty genes. Biochem. Biophys. Res. Commun. 285, 1084-1088. (Pubitemid 32912891)
16. Abe, M. & Naski, M. (2004). Regulation of sprouty expression by PLCgamma and calcium-dependent signals. Biochem. Biophys. Res. Commun. 323, 1040-1047. (Pubitemid 39243423)
17. Akbulut, S., Reddi, R. A., Aggarwal, P., Ambardekar, C., Cancian, B., Kim, M. K. et al. (2010). Sprouty proteins inhibit receptor-mediated activation of phos-phatidylinositol-specific phospholipase C. Mol. Biol. Cell, 21, 3487-3496.
18. Lim, J., Yusoff, P., Wong, E. S., Chandramouli, S., Lao, D. H., Fong, C. W. & Guy, G. R. (2002). The cysteine-rich sprouty translocation domain targets mitogen-activated protein kinase inhibitory proteins to phosphatidylinositol 4,5-bisphosphate in plasma membranes. Mol. Cell. Biol. 22, 7953-7966. (Pubitemid 35217304)
19. Rhee, S. G. (2001). Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70, 281-312. (Pubitemid 32662212)
20. q signaling cascade by the human immunodeficiency virus envelope is required for virus entry. J. Virol. 82, 9191-9205.
21. 2+requirement, and regulation of M current. J. Gen. Physiol. 126, 243-262. (Pubitemid 41252785)
22. Cenni, B. & Picard, D. (1999). Two compounds commonly used for phospholipase C inhibition activate the nuclear estrogen receptors. Biochem. Biophys. Res. Commun. 261, 340-344. (Pubitemid 29392478)
23. Babe, L. M., Rose, J. & Craik, C. S. (1995). Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation. Proc. Natl Acad. Sci. USA, 92, 10069-10073.
24. Hammond, G. R., Dove, S. K., Nicol, A., Pinxteren, J. A., Zicha, D. & Schiavo, G. (2006). Elimination of plasma membrane phosphatidylinositol (4,5)-bispho-sphate is required for exocytosis from mast cells. J. Cell Sci. 119, 2084-2094. (Pubitemid 43904963)
25. 2. Biochem. J. 422, 23-35.
26. Manders, E. M. M., Verbeek, J. F. & Aten, J. A. (1993). Measurement of colocalization of objects in dual color confocal images. J. Microsc. 169, 375-382. (Pubitemid 23119681)
27. 2+signaling. J. Biol. Chem. 279, 11967-11975. (Pubitemid 38401702)
28. Nutt, S. L., Dingwell, K. S., Holt, C. E. & Amaya, E. (2001). Xenopus Sprouty2 inhibits FGF-mediated gastrulation movements but does not affect meso-derm induction and patterning. Genes Dev. 15, 1152-1166. (Pubitemid 32417307)
29. Sivak, J. M., Petersen, L. F. & Amaya, E. (2005). FGF signal interpretation is directed by Sprouty and Spred proteins during mesoderm formation. Dev. Cell, 8, 689-701. (Pubitemid 40585292)
30. Fernandes, F., Chen, K., Ehrlich, L. S., Jin, J., Chen, M. H., Medina, G. N. et al. (2011). Phosphoinositides direct equine infectious anemia virus Gag trafficking and release. Traffic, 4, 438-451.
31. Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H. & Summers, M. F. (2006). Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl Acad. Sci. USA, 103, 11364-11369. (Pubitemid 44156523)
32. Medina, G., Pincetic, A., Ehrlich, L. S., Zhang, Y., Tang, Y., Leis, J. & Carter, C. A. (2008). Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting. Virology, 377, 30-38. (Pubitemid 351799835)
33. Hall, A. B., Jura, N., DaSilva, J., Jang, Y. J., Gong, D. & Bar-Sagi, D. (2003). hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Curr. Biol. 13, 308-314. (Pubitemid 36230021)
34. Ehrlich, L. S., Krausslich, H-G., Wimmer, E. & Carter, C. (1990). Expression in Escherichia coli and purification of human immunodeficiency virus type 1 capsid protein (p24). AIDS Res. Hum. Retroviruses, 6, 1169-1175. (Pubitemid 20363327)